Mechanisms of multidrug resistance in cancer
Jean-Pierre Gillet1, Michael M Gottesman
1Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Abstract:
The development of multidrug resistance (MDR) to chemotherapy remains a major challenge in the treatment of cancer. Resistance exists against every effective anticancer drug and can develop by numerous mechanisms including decreased drug uptake, increased drug efflux, activation of detoxifying systems, activation of DNA repair mechanisms, evasion of drug-induced apoptosis, etc. In the first part of this chapter, we briefly summarize the current knowledge on individual cellular mechanisms responsible for MDR, with a special emphasis on ATP-binding cassette transporters, perhaps the main theme of this textbook. Although extensive work has been done to characterize MDR mechanisms in vitro, the translation of this knowledge to the clinic has not been crowned with success. Therefore, identifying genes and mechanisms critical to the development of MDR in vivo and establishing a reliable method for analyzing clinical samples could help to predict the development of resistance and lead to treatments designed to circumvent it. Our thoughts about translational research needed to achieve significant progress in the understanding of this complex phenomenon are therefore discussed in a third section. The pleotropic response of cancer cells to chemotherapy is summarized in a concluding diagram.
Insights
Multidrug resistance (MDR) in cancer treatment is a major challenge. Understanding cellular mechanisms and improving in vivo studies are crucial for developing effective cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Multidrug resistance (MDR) is a significant obstacle in cancer chemotherapy.
- Resistance arises from diverse cellular mechanisms, including altered drug transport and metabolism.
- ATP-binding cassette transporters play a key role in MDR.
Purpose of the Study:
- To review cellular mechanisms underlying MDR.
- To highlight the limitations of in vitro studies in translating findings to clinical practice.
- To discuss the need for translational research in understanding and overcoming MDR.
Main Methods:
- Summary of current knowledge on MDR mechanisms.
- Emphasis on ATP-binding cassette transporters.
- Discussion of translational research strategies.
Main Results:
- MDR involves multiple cellular processes like reduced drug uptake and increased efflux.
- In vitro characterization of MDR mechanisms has not translated effectively to clinical success.
- Identifying in vivo mechanisms and reliable clinical sample analysis are critical.
Conclusions:
- Translational research is essential for significant progress in understanding MDR.
- Developing methods to predict and circumvent resistance is key for improved cancer treatment.
- A comprehensive understanding of MDR's pleiotropic response is needed.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers
Resistivity
Resistance
Equivalent Resistance


